Abstract:Background 3-oxoacyl-ACP synthase (OXSM) is a key enzyme in the mitochondrial fatty acid synthesis pathway, playing a role in the biosynthesis of lipoic acid as well as long-chain fatty acids required for mitochondrial function. Recent studies have shown that OXSM is involved in the progression of various tumors, but its role in colon cancer tumorigenesis remains to be investigated. The aim of this study is to investigate the function and underlying mechanism of OXSM in colon cancer. Methods Tissue microarrays and immunohistochemistry are used to analyze OXSM expression and its correlation with clinicopathological parameters. The upstream microRNA is identified by SmallRNA-seq and bioinformatics analyses. Cell growth and cell migration are measured in HCT116 cells simultaneously depleted of microRNA and OXSM. The RNA-seq is adopted to determine the signaling pathway of OXSM. The mouse xenograft assay is studied to confirm the role of OXSM in vivo. Results In this study, we find that OXSM level is significantly low in colon cancer patients, and low OXSM expression correlates with poor patient survival in colon cancer. The SmallRNA-seq analysis and biofunctional tests reveal that miR-4659a-3p is a novel microRNA of OXSM. Depletion of OXSM leads to the promotion of cell proliferation and migration in colon cancer, while simultaneously downregulation of miR-4659a-3p rescues the promotive phenomenon in cells ablated with OXSM. RNA-seq result shows that OXSM mediated the regulation of cytokine and chemokine biosynthesis and metabolism, including EGR1, HMOX1, ZFP36, TLR3, IL1RAP, TLR1, IFIH1, P2RX7. Moreover, OXSM depletion nude mice exhibit decreased level of cytokine and chemokine in tumor tissues and are more prone to tumorigenesis. Conclusions miR-4659a-3p promotes the formation of colon cancer by inhibiting cytokine and chemokine biosynthesis and metabolism via OXSM, providing a potential target for colon cancer diagnosis and therapy.

OSI-027 Inhibits the Tumorigenesis of Colon Cancer Through Mediation of C-Myc/foxo3a/puma Axis

Targeting Mtor Suppressed Colon Cancer Growth Through 4ebp1/eif4e/puma Pathway

The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2

OSI-027 Alleviates Oxaliplatin Chemoresistance in Gastric Cancer Cells by Suppressing P-gp Induction.

Osi-027 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine Both in Vitro and in Vivo

Study on the effects of rapamycin and the mTORC1/2 dual inhibitor OSI-027 on the metabolism of colon cancer cells based on UPLC-MS/MS metabolomics

Pazopanib, a Novel Multi-Kinase Inhibitor, Shows Potent Antitumor Activity in Colon Cancer Through PUMA-mediated Apoptosis

MCT1 Relieves Osimertinib-Induced CRC Suppression by Promoting Autophagy Through the LKB1/AMPK Signaling

Inhibition of Mtor Suppresses Human Gallbladder Carcinoma Cell Proliferation and Enhances the Cytotoxicity of 5-Fluorouracil by Downregulating MDR1 Expression.

Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer

Autophagic Degradation of Foxo3a Represses the Expression of Puma to Block Cell Apoptosis in Cisplatin-Resistant Osteosarcoma Cells

IDDF2024-ABS-0222 Mir-4659A-3p Promotes the Proliferation of Colon Cancer Mediated by 3-Oxoacyl-acp Synthase (OXSM)

Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis

MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis

COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells

Combined Inhibition of Mek and Mtor Signaling Inhibits Initiation and Progression of Colorectal Cancer

Mechanism of inhibition of growth and metastasis of colon cancer by celecoxib analog OSU-03013 via wnt signaling pathway

Effect of ARK5 on the Anti-Tumour Activity of OSI-027 Via Regulation of Epithelial-Mesenchymal Transition in Pancreatic Cancer.

Mtor Signaling Pathway is a Target for the Treatment of Colorectal Cancer

Significance of Mtor Signaling and Its Inhibitor Against Cancer Stem-Like Cells in Colorectal Cancer

Mir-624-5p Promoted Tumorigenesis and Metastasis by Suppressing Hippo Signaling Through Targeting PTPRB in Osteosarcoma Cells.